In a sobering turn of events, 23andMe, the once-celebrated pioneer of direct-to-consumer genetic testing, has filed for Chapter 11 bankruptcy. This development has ignited a critical conversation about corporate governance, executive compensation, and the ethical stewardship of sensitive consumer data.
Read more
Danish biotech Fuse Vectors is announcing a funding round as it re-imagines the engine of work to deliver gene therapy (the technique that modifies a person's genes to treat or cure disease). Its tech replaces 1980s cell-based methods with revolutionary cell-free technology, making gene therapy more accessible and faster.
Read more
Studying twins and the effects of one twin on Space travel. Genetics information can help heal us.
Read more